Review of economic analyses of treatment for non-small–cell lung cancer (NSCLC)
A Vergnenègre, C Chouaïd - Expert review of pharmacoeconomics …, 2018 - Taylor & Francis
Introduction: During the past few years, medical–economic evaluation of lung cancers (LCs)
has become unavoidable. Total management costs have been rising constantly, with values …
has become unavoidable. Total management costs have been rising constantly, with values …
[引用][C] Review of economic analyses of treatment for non-small-cell lung cancer (NSCLC).
A Vergnenègre, C Chouaïd - Expert Review of Pharmacoeconomics …, 2018 - europepmc.org
During the past few years, medical-economic evaluation of lung cancers (LCs) has become
unavoidable. Total management costs have been rising constantly, with values almost …
unavoidable. Total management costs have been rising constantly, with values almost …
Review of economic analyses of treatment for non-small-cell lung cancer (NSCLC)
A Vergnenègre, C Chouaïd - Expert review of …, 2018 - pubmed.ncbi.nlm.nih.gov
Introduction During the past few years, medical-economic evaluation of lung cancers (LCs)
has become unavoidable. Total management costs have been rising constantly, with values …
has become unavoidable. Total management costs have been rising constantly, with values …